title: Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
abstract: OBJECTIVE
  Deutetrabenazine is a novel molecule containing deuterium, which attenuates CYP2D6 metabolism and increases active metabolite half-lives and may therefore lead to stable systemic exposure while preserving key pharmacological activity.
  
  
  OBJECTIVE
  To evaluate efficacy and safety of deutetrabenazine treatment to control chorea associated with Huntington disease.
  
  
  METHODS
  Ninety ambulatory adults diagnosed with manifest Huntington disease and a baseline total maximal chorea score of 8 or higher (range, 0-28; lower score indicates less chorea) were enrolled from August 2013 to August 2014 and randomized to receive deutetrabenazine (n = 45) or placebo (n = 45) in a double-blind fashion at 34 Huntington Study Group sites.
  
  
  METHODS
  Deutetrabenazine or placebo was titrated to optimal dose level over 8 weeks and maintained for 4 weeks, followed by a 1-week washout.
  
  
  METHODS
  Primary end point was the total maximal chorea score change from baseline (the average of values from the screening and day-0 visits) to maintenance therapy (the average of values from the week 9 and 12 visits) obtained by in-person visits. This study was designed to detect a 2.7-unit treatment difference in scores. The secondary end points, assessed hierarchically, were the proportion of patients who achieved treatment success on the Patient Global Impression of Change (PGIC) and on the Clinical Global Impression of Change (CGIC), the change in 36-Item Short Form- physical functioning subscale score (SF-36), and the change in the Berg Balance Test.
  
  
  RESULTS
  Ninety patients with Huntington disease (mean age, 53.7 years; 40 women [44.4%]) were enrolled. In the deutetrabenazine group, the mean total maximal chorea scores improved from 12.1 (95% CI, 11.2-12.9) to 7.7 (95% CI, 6.5-8.9), whereas in the placebo group, scores improved from 13.2 (95% CI, 12.2-14.3) to 11.3 (95% CI, 10.0-12.5); the mean between-group difference was -2.5 units (95% CI, -3.7 to -1.3) (P < .001). Treatment success, as measured by the PGIC, occurred in 23 patients (51%) in the deutetrabenazine group vs 9 (20%) in the placebo group (P = .002). As measured by the CGIC, treatment success occurred in 19 patients (42%) in the deutetrabenazine group vs 6 (13%) in the placebo group (P = .002). In the deutetrabenazine group, the mean SF-36 physical functioning subscale scores decreased from 47.5 (95% CI, 44.3-50.8) to 47.4 (44.3-50.5), whereas in the placebo group, scores decreased from 43.2 (95% CI, 40.2-46.3) to 39.9 (95% CI, 36.2-43.6), for a treatment benefit of 4.3 (95% CI, 0.4 to 8.3) (P = .03). There was no difference between groups (mean difference of 1.0 unit; 95% CI, -0.3 to 2.3; P = .14), for improvement in the Berg Balance Test, which improved by 2.2 units (95% CI, 1.3-3.1) in the deutetrabenazine group and by 1.3 units (95% CI, 0.4-2.2) in the placebo group. Adverse event rates were similar for deutetrabenazine and placebo, including depression, anxiety, and akathisia.
  
  
  CONCLUSIONS
  Among patients with chorea associated with Huntington disease, the use of deutetrabenazine compared with placebo resulted in improved motor signs at 12 weeks. Further research is needed to assess the clinical importance of the effect size and to determine longer-term efficacy and safety.
  
  
  BACKGROUND
  clinicaltrials.gov Identifier: NCT01795859.
authors.affiliation: Harvard Medical School, Boston, Massachusetts.
authors.forename: Samuel
authors.initials: S
authors.lastname: Frank
authors.affiliation: Virginia Commonwealth University, Richmond, Virginia.
authors.forename: Claudia M
authors.initials: CM
authors.lastname: Testa
authors.affiliation: Teva Pharmaceuticals Ltd, Frazer, Pennsylvania.
authors.forename: David
authors.initials: D
authors.lastname: Stamler
authors.affiliation: Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York.
authors.forename: Elise
authors.initials: E
authors.lastname: Kayson
authors.affiliation: CSD Biostatistics, Tucson, Arizona.
authors.forename: Charles
authors.initials: C
authors.lastname: Davis
authors.affiliation: Duke University, Durham, North Carolina.
authors.forename: Mary C
authors.initials: MC
authors.lastname: Edmondson
authors.affiliation: Huntington Study Group, Rochester, New York.
authors.forename: Shari
authors.initials: S
authors.lastname: Kinel
authors.affiliation: Centre of Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.
authors.forename: Blair
authors.initials: B
authors.lastname: Leavitt
authors.affiliation: University of Rochester, Rochester, New York.
authors.forename: David
authors.initials: D
authors.lastname: Oakes
authors.affiliation: Wake Forest School of Medicine, Winston-Salem, North Carolina.
authors.forename: Christine
authors.initials: C
authors.lastname: O'Neill
authors.affiliation: Medical University of South Carolina, Charleston, South Carolina.
authors.forename: Christina
authors.initials: C
authors.lastname: Vaughan
authors.affiliation: Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York.
authors.forename: Jody
authors.initials: J
authors.lastname: Goldstein
authors.affiliation: Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York.
authors.forename: Margaret
authors.initials: M
authors.lastname: Herzog
authors.affiliation: Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York.
authors.forename: Victoria
authors.initials: V
authors.lastname: Snively
authors.affiliation: Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York.
authors.forename: Jacquelyn
authors.initials: J
authors.lastname: Whaley
authors.affiliation: Teva Pharmaceuticals Ltd, Frazer, Pennsylvania.
authors.forename: Cynthia
authors.initials: C
authors.lastname: Wong
authors.affiliation: Hereditary Neurological Disease Centre, Wichita, Kansas.
authors.forename: Greg
authors.initials: G
authors.lastname: Suter
authors.affiliation: Baylor College of Medicine, Houston, Texas.
authors.forename: Joseph
authors.initials: J
authors.lastname: Jankovic
authors.affiliation: Baylor College of Medicine, Houston, Texas.
authors.forename: Joohi
authors.initials: J
authors.lastname: Jimenez-Shahed
authors.affiliation: Baylor College of Medicine, Houston, Texas.
authors.forename: Christine
authors.initials: C
authors.lastname: Hunter
authors.affiliation: Vanderbilt University Medical Center, Nashville, Tennessee.
authors.forename: Daniel O
authors.initials: DO
authors.lastname: Claassen
authors.affiliation: Vanderbilt University Medical Center, Nashville, Tennessee.
authors.forename: Olivia C
authors.initials: OC
authors.lastname: Roman
authors.affiliation: University of Alabama School of Medicine, Birmingham, Alabama.
authors.forename: Victor
authors.initials: V
authors.lastname: Sung
authors.affiliation: University of Alabama School of Medicine, Birmingham, Alabama.
authors.forename: Jenna
authors.initials: J
authors.lastname: Smith
authors.affiliation: Columbia University, New York, New York.
authors.forename: Sarah
authors.initials: S
authors.lastname: Janicki
authors.affiliation: Columbia University, New York, New York.
authors.forename: Ronda
authors.initials: R
authors.lastname: Clouse
authors.affiliation: Boston University Medical Campus, Boston, Massachusetts.
authors.forename: Marie
authors.initials: M
authors.lastname: Saint-Hilaire
authors.affiliation: Boston University Medical Campus, Boston, Massachusetts.
authors.forename: Anna
authors.initials: A
authors.lastname: Hohler
authors.affiliation: Boston University Medical Campus, Boston, Massachusetts.
authors.forename: Denyse
authors.initials: D
authors.lastname: Turpin
authors.affiliation: Boston University Medical Campus, Boston, Massachusetts.
authors.forename: Raymond C
authors.initials: RC
authors.lastname: James
authors.affiliation: University of Florida College of Medicine, Gainesville, Florida.
authors.forename: Ramon
authors.initials: R
authors.lastname: Rodriguez
authors.affiliation: University of Florida College of Medicine, Gainesville, Florida.
authors.forename: Kyle
authors.initials: K
authors.lastname: Rizer
authors.affiliation: Georgetown University, Washington, DC.
authors.forename: Karen E
authors.initials: KE
authors.lastname: Anderson
authors.affiliation: Georgetown University, Washington, DC.
authors.forename: Hope
authors.initials: H
authors.lastname: Heller
authors.affiliation: Columbia University, New York, New York.
authors.forename: Alexis
authors.initials: A
authors.lastname: Carlson
authors.affiliation: Washington University School of Medicine, St Louis, Missouri.
authors.forename: Susan
authors.initials: S
authors.lastname: Criswell
authors.affiliation: Washington University School of Medicine, St Louis, Missouri.
authors.forename: Brad A
authors.initials: BA
authors.lastname: Racette
authors.affiliation: Greenville Health System, Greenville, South Carolina22University of South Carolina Medical School, Greenville, South Carolina.
authors.forename: Fredy J
authors.initials: FJ
authors.lastname: Revilla
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Frederick
authors.initials: F
authors.lastname: Nucifora
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Russell L
authors.initials: RL
authors.lastname: Margolis
authors.affiliation: Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: MaryJane
authors.initials: M
authors.lastname: Ong
authors.affiliation: Ottowa Parkinson's and Neurodegenerative Disorders Clinic, Ottawa, Canada.
authors.forename: Tilak
authors.initials: T
authors.lastname: Mendis
authors.affiliation: Ottowa Parkinson's and Neurodegenerative Disorders Clinic, Ottawa, Canada.
authors.forename: Neila
authors.initials: N
authors.lastname: Mendis
authors.affiliation: University of Miami Health, Miami, Florida.
authors.forename: Carlos
authors.initials: C
authors.lastname: Singer
authors.affiliation: University of Miami Health, Miami, Florida.
authors.forename: Monica
authors.initials: M
authors.lastname: Quesada
authors.affiliation: University of Iowa Carver College of Medicine, Iowa City, Iowa.
authors.forename: Jane S
authors.initials: JS
authors.lastname: Paulsen
authors.affiliation: University of Iowa Carver College of Medicine, Iowa City, Iowa.
authors.forename: Thomas
authors.initials: T
authors.lastname: Brashers-Krug
authors.affiliation: University of Iowa Carver College of Medicine, Iowa City, Iowa.
authors.forename: Amanda
authors.initials: A
authors.lastname: Miller
authors.affiliation: University of Iowa Carver College of Medicine, Iowa City, Iowa.
authors.forename: Jane
authors.initials: J
authors.lastname: Kerr
authors.affiliation: University of Kansas Medical Center, Kansas City.
authors.forename: Richard M
authors.initials: RM
authors.lastname: Dubinsky
authors.affiliation: University of Kansas Medical Center, Kansas City.
authors.forename: Carolyn
authors.initials: C
authors.lastname: Gray
authors.affiliation: Emory University, Atlanta, Georgia.
authors.forename: Stewart A
authors.initials: SA
authors.lastname: Factor
authors.affiliation: Emory University, Atlanta, Georgia.
authors.forename: Elaine
authors.initials: E
authors.lastname: Sperin
authors.affiliation: Albany Medical College, Albany, New York.
authors.forename: Eric
authors.initials: E
authors.lastname: Molho
authors.affiliation: Albany Medical College, Albany, New York.
authors.forename: Mary
authors.initials: M
authors.lastname: Eglow
authors.affiliation: Albany Medical College, Albany, New York.
authors.forename: Sharon
authors.initials: S
authors.lastname: Evans
authors.affiliation: Rocky Mountain Movement Disorders Center, Englewood, Colorado.
authors.forename: Rajeev
authors.initials: R
authors.lastname: Kumar
authors.affiliation: Rocky Mountain Movement Disorders Center, Englewood, Colorado.
authors.forename: Christina
authors.initials: C
authors.lastname: Reeves
authors.affiliation: University of Washington, Seattle, Washington.
authors.forename: Ali
authors.initials: A
authors.lastname: Samii
authors.affiliation: Centre hospitalier de l'Université de Montréal, Montreal, Québec, Canada.
authors.forename: Sylvain
authors.initials: S
authors.lastname: Chouinard
authors.affiliation: Hôpital Notre-Dame, Montréal, Québec, Canada.
authors.forename: Monica
authors.initials: M
authors.lastname: Beland
authors.affiliation: Duke University, Durham, North Carolina.
authors.forename: Burton L
authors.initials: BL
authors.lastname: Scott
authors.affiliation: Duke University, Durham, North Carolina.
authors.forename: Patrick T
authors.initials: PT
authors.lastname: Hickey
authors.affiliation: North York General Hospital, Toronto, Canada.
authors.forename: Sherali
authors.initials: S
authors.lastname: Esmail
authors.affiliation: North York General Hospital, Toronto, Canada35University of Toronto, Toronto, Ontario, Canada36Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
authors.forename: Wai Lun Alan
authors.initials: WL
authors.lastname: Fung
authors.affiliation: North York General Hospital, Toronto, Canada35University of Toronto, Toronto, Ontario, Canada.
authors.forename: Clare
authors.initials: C
authors.lastname: Gibbons
authors.affiliation: North York General Hospital, Toronto, Canada.
authors.forename: Lina
authors.initials: L
authors.lastname: Qi
authors.affiliation: Cooper University Hospital, Camden, New Jersey.
authors.forename: Amy
authors.initials: A
authors.lastname: Colcher
authors.affiliation: Cooper University Hospital, Camden, New Jersey.
authors.forename: Cory
authors.initials: C
authors.lastname: Hackmyer
authors.affiliation: Cooper University Hospital, Camden, New Jersey.
authors.forename: Andrew
authors.initials: A
authors.lastname: McGarry
authors.affiliation: The Movement Disorders Clinic Oklahoma, Tulsa.
authors.forename: Kevin
authors.initials: K
authors.lastname: Klos
authors.affiliation: South Shore Neurologic Associates, Islip, New York.
authors.forename: Mark
authors.initials: M
authors.lastname: Gudesblatt
authors.affiliation: South Shore Neurologic Associates, Islip, New York.
authors.forename: Lori
authors.initials: L
authors.lastname: Fafard
authors.affiliation: South Shore Neurologic Associates, Islip, New York.
authors.forename: Laura
authors.initials: L
authors.lastname: Graffitti
authors.affiliation: Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
authors.forename: Daniel P
authors.initials: DP
authors.lastname: Schneider
authors.affiliation: Parkinson's Institute and Clinical Center, Sunnyvale, California.
authors.forename: Rohit
authors.initials: R
authors.lastname: Dhall
authors.affiliation: Indiana University School of Medicine, Indianapolis.
authors.forename: Joanne M
authors.initials: JM
authors.lastname: Wojcieszek
authors.affiliation: University of Louisville, Louisville, Kentucky.
authors.forename: Kathrin
authors.initials: K
authors.lastname: LaFaver
authors.affiliation: University of Cincinnati, Cincinnati, Ohio.
authors.forename: Andrew
authors.initials: A
authors.lastname: Duker
authors.affiliation: University of Cincinnati, Cincinnati, Ohio.
authors.forename: Erin
authors.initials: E
authors.lastname: Neefus
authors.affiliation: University of Cincinnati, Cincinnati, Ohio.
authors.forename: Hilary
authors.initials: H
authors.lastname: Wilson-Perez
authors.affiliation: University of Utah Health Care, Salt Lake City, Utah46Banner Sun Health Research Institute, Sun City, Arizona.
authors.forename: David
authors.initials: D
authors.lastname: Shprecher
authors.affiliation: Medical College of Wisconsin, Milwaukee, Wisconsin.
authors.forename: Paola
authors.initials: P
authors.lastname: Wall
authors.affiliation: Medical College of Wisconsin, Milwaukee, Wisconsin.
authors.forename: Karen A
authors.initials: KA
authors.lastname: Blindauer
authors.affiliation: Medical College of Wisconsin, Milwaukee, Wisconsin.
authors.forename: Lynn
authors.initials: L
authors.lastname: Wheeler
authors.affiliation: University of Vermont Medical Center, Burlington, Vermont.
authors.forename: James T
authors.initials: JT
authors.lastname: Boyd
authors.affiliation: University of Vermont Medical Center, Burlington, Vermont.
authors.forename: Emily
authors.initials: E
authors.lastname: Houston
authors.affiliation: University of Nevada School of Medicine, Reno, Nevada.
authors.forename: Eric S
authors.initials: ES
authors.lastname: Farbman
authors.affiliation: Evergreen Neuroscience Institute, Kirkland, Washington.
authors.forename: Pinky
authors.initials: P
authors.lastname: Agarwal
authors.affiliation: University of Rochester, Rochester, New York.
authors.forename: Shirley W
authors.initials: SW
authors.lastname: Eberly
authors.affiliation: University of Rochester, Rochester, New York.
authors.forename: Arthur
authors.initials: A
authors.lastname: Watts
authors.affiliation: Banner Alzheimer's Institute, Phoenix, Arizona.
authors.forename: Pierre N
authors.initials: PN
authors.lastname: Tariot
authors.affiliation: Feinstein Institute for Medical Research, Manhasset, New York.
authors.forename: Andrew
authors.initials: A
authors.lastname: Feigin
authors.affiliation: Harvard University, Boston, Massachusetts.
authors.forename: Scott
authors.initials: S
authors.lastname: Evans
authors.affiliation: University of Rochester, Rochester, New York.
authors.forename: Chris
authors.initials: C
authors.lastname: Beck
authors.affiliation: University of Rochester, Rochester, New York.
authors.forename: Constance
authors.initials: C
authors.lastname: Orme
authors.affiliation: University of Rochester, Rochester, New York.
authors.forename: Jon
authors.initials: J
authors.lastname: Edicola
authors.affiliation: Harvard University, Boston, Massachusetts.
authors.forename: Emily
authors.initials: E
authors.lastname: Christopher
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D002819:Chorea / Q000188:drug therapy*; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D060046:Maintenance Chemotherapy / Q000379:methods; D008297:Male; D008875:Middle Aged; D013747:Tetrabenazine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018759:Adrenergic Uptake Inhibitors; D019389:Cytochrome P-450 CYP2D6; C000609690:deutetrabenazine; D013747:Tetrabenazine